Synfacts 2011(2): 0119-0119  
DOI: 10.1055/s-0030-1259212
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Telcagepant

Contributor(s):Philip Kocienski
F. Xu et al.*
Merck Research Laboratories, Rahway, USA
Asymmetric Synthesis of Telcagepant, a CGRP Receptor Antagonist for the Treatment of Migraine
J. Org. Chem.  2010,  75:  7829-7841  
Further Information

Publication History

Publication Date:
19 January 2011 (online)


Significance

Telcagepant is a selective antagonist of calcitonin gene related peptide (CGRP) that is in phase clinical trials for the treatment of migraine. The synthesis featured an enantioselective 1,4-addition of nitromethane, which is the first ­application of iminium organocatalysis (B ♦  D) on an industrial scale and a highly stereoselective Doebner-Knoevenagel condensation that created the enamide F.

Comment

The formation of desfluoro impurities that accompanied the hydrogenation of F was minimized by conducting the reaction in the presence of LiCl. The mixture of caprolactams I and J (2:1) was converted into pure J by crystallization-induced diastereoselection. The synthesis was accomplished in 27% overall yield and involved only three isolated crystalline intermediates (F, J and K).